Filing Details
- Accession Number:
- 0000899243-22-014397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-08 21:41:30
- Reporting Period:
- 2022-04-07
- Accepted Time:
- 2022-04-08 21:41:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-07 | 1,649 | $26.10 | 669,594 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 1,649 | $151.42 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 2,100 | $26.10 | 670,045 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 2,100 | $152.59 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 4,692 | $26.10 | 672,637 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 4,692 | $153.38 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 2,400 | $26.10 | 670,345 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 2,400 | $154.36 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 3,828 | $26.10 | 671,773 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 3,828 | $155.83 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 1,900 | $26.10 | 669,845 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 1,900 | $156.48 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-07 | 474 | $26.10 | 668,419 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-07 | 474 | $157.23 | 667,945 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 1,649 | $0.00 | 1,649 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 2,100 | $0.00 | 2,100 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 4,692 | $0.00 | 4,692 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 2,400 | $0.00 | 2,400 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 3,828 | $0.00 | 3,828 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 1,900 | $0.00 | 1,900 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-07 | 474 | $0.00 | 474 | $26.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 83,566 | 2022-08-20 | No | 4 | M | Direct | |
| 81,466 | 2022-08-20 | No | 4 | M | Direct | |
| 76,774 | 2022-08-20 | No | 4 | M | Direct | |
| 74,374 | 2022-08-20 | No | 4 | M | Direct | |
| 70,546 | 2022-08-20 | No | 4 | M | Direct | |
| 68,646 | 2022-08-20 | No | 4 | M | Direct | |
| 68,172 | 2022-08-20 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $150.90 to $151.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $151.98 to $152.92. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $153.00 to $153.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $154.03 to $154.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $155.14 to $156.13. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $156.15 to $157.10. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $157.17 to $157.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16.
Billionaire Hedge Funds
